基于 2 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Discover the full record of transactions filed by Guy Wendy, Directeur Administratif. Director active across 1 company, notably Processa Pharmaceuticals, Inc.. Aggregated, 10 disclosures have been recorded. Split: 3 buys · 0 sell. Total volume traded: €12k. History available since 12 October 2023. The latest transaction was filed on 30 April 2026 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Guy Wendy is Directeur Administratif and Chief Administrative Officer at Processa Pharmaceuticals, Inc. Across 10 filed disclosures, the 10 sampled filings cover the period from 2021-08-09 to 2026-05-01, with EUR 12051 of buys and EUR 0 of sells, and the most frequent transaction nature is Option exercise.